Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation
Authors:
- Chia-Cheng LiCLChia-Cheng Li
- Calvin Yu-Chian ChenCalvin Yu-Chian Chen
- Hsin-Yi LoHLHsin-Yi Lo
- Wen-Yu ChengWCWen-Yu Cheng
- Chang-Hsien LeeCLChang-Hsien Lee
- Shi-Zhe YangSYShi-Zhe Yang
- Shih-Lu WuSWShih-Lu Wu
- Chien-Yun HsiangCHChien-Yun Hsiang
- Tin-Yun HoTHTin-Yun Ho
- 1 November 2010
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 132 (2) , 429-437
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Comprehensive evaluation of a novel nuclear factor‐κB inhibitor, quinoclamine, by transcriptomic analysisBritish Journal of Pharmacology, 2009
- Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancerThe Breast, 2008
- Relationship Between San-Huang-Xie-Xin-Tang and Its Herbal Components on the Gene Expression Profiles in HepG2 CellsThe American Journal of Chinese Medicine, 2008
- Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cellsPharmacological Research, 2007
- Expression profiling of glial genes during Drosophila embryogenesisDevelopmental Biology, 2006
- Cytochromes P450 as versatile biocatalystsJournal of Biotechnology, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- The Genetic Association DatabaseNature Genetics, 2004
- Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate CancerNew England Journal of Medicine, 1998